Literature DB >> 32439824

Reciprocity Between Skeletal Muscle AMPK Deletion and Insulin Action in Diet-Induced Obese Mice.

Louise Lantier1,2, Ashley S Williams3, Ian M Williams3, Amanda Guerin3, Deanna P Bracy3, Mickael Goelzer3, Marc Foretz4, Benoit Viollet4, Curtis C Hughey3, David H Wasserman3,2.   

Abstract

Insulin resistance due to overnutrition places a burden on energy-producing pathways in skeletal muscle (SkM). Nevertheless, energy state is not compromised. The hypothesis that the energy sensor AMPK is necessary to offset the metabolic burden of overnutrition was tested using chow-fed and high-fat (HF)-fed SkM-specific AMPKα1α2 knockout (mdKO) mice and AMPKα1α2lox/lox littermates (wild-type [WT]). Lean mdKO and WT mice were phenotypically similar. HF-fed mice were equally obese and maintained lean mass regardless of genotype. Results did not support the hypothesis that AMPK is protective during overnutrition. Paradoxically, mdKO mice were more insulin sensitive. Insulin-stimulated SkM glucose uptake was approximately twofold greater in mdKO mice in vivo. Furthermore, insulin signaling, SkM GLUT4 translocation, hexokinase activity, and glycolysis were increased. AMPK and insulin signaling intersect at mammalian target of rapamycin (mTOR), a critical node for cell proliferation and survival. Basal mTOR activation was reduced by 50% in HF-fed mdKO mice, but was normalized by insulin stimulation. Mitochondrial function was impaired in mdKO mice, but energy charge was preserved by AMP deamination. Results show a surprising reciprocity between SkM AMPK signaling and insulin action that manifests with diet-induced obesity, as insulin action is preserved to protect fundamental energetic processes in the muscle.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32439824      PMCID: PMC7372072          DOI: 10.2337/db19-1074

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  67 in total

Review 1.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

2.  A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.

Authors:  T Haruta; T Uno; J Kawahara; A Takano; K Egawa; P M Sharma; J M Olefsky; M Kobayashi
Journal:  Mol Endocrinol       Date:  2000-06

3.  Contraction-stimulated muscle glucose transport and GLUT-4 surface content are dependent on glycogen content.

Authors:  W Derave; S Lund; G D Holman; J Wojtaszewski; O Pedersen; E A Richter
Journal:  Am J Physiol       Date:  1999-12

4.  Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans.

Authors:  L Rossetti; Y T Lee; J Ruiz; S C Aldridge; H Shamoon; G Boden
Journal:  Am J Physiol       Date:  1993-11

5.  Role of Grb10 in mTORC1-dependent regulation of insulin signaling and action in human skeletal muscle cells.

Authors:  Ashlin M Edick; Olivia Auclair; Sergio A Burgos
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-12-03       Impact factor: 4.310

6.  S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.

Authors:  Victor Aguilar; Samira Alliouachene; Athanassia Sotiropoulos; Andrew Sobering; Yoni Athea; Fatima Djouadi; Sylvain Miraux; Eric Thiaudière; Marc Foretz; Benoit Viollet; Philippe Diolez; Jean Bastin; Paule Benit; Pierre Rustin; David Carling; Marco Sandri; Renée Ventura-Clapier; Mario Pende
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

7.  AMPK and insulin action--responses to ageing and high fat diet.

Authors:  Christian Frøsig; Thomas E Jensen; Jacob Jeppesen; Christian Pehmøller; Jonas T Treebak; Stine J Maarbjerg; Jonas M Kristensen; Lykke Sylow; Thomas J Alsted; Peter Schjerling; Bente Kiens; Jørgen F P Wojtaszewski; Erik A Richter
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

8.  Glucose metabolism in vivo in four commonly used inbred mouse strains.

Authors:  Eric D Berglund; Candice Y Li; Greg Poffenberger; Julio E Ayala; Patrick T Fueger; Shannon E Willis; Marybeth M Jewell; Alvin C Powers; David H Wasserman
Journal:  Diabetes       Date:  2008-04-08       Impact factor: 9.461

9.  Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice.

Authors:  Nobuharu Fujii; Richard C Ho; Yasuko Manabe; Niels Jessen; Taro Toyoda; William L Holland; Scott A Summers; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2008-08-26       Impact factor: 9.461

10.  The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice.

Authors:  Katarina Marcinko; Adam L Bujak; James S V Lally; Rebecca J Ford; Tammy H Wong; Brennan K Smith; Bruce E Kemp; Yonchu Jenkins; Wei Li; Todd M Kinsella; Yasumichi Hitoshi; Gregory R Steinberg
Journal:  Mol Metab       Date:  2015-06-15       Impact factor: 7.422

View more
  3 in total

1.  Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle.

Authors:  B Vandanmagsar; Y Yu; C Simmler; T N Dang; P Kuhn; A Poulev; D M Ribnicky; G F Pauli; Z E Floyd
Journal:  Biomed Pharmacother       Date:  2021-09-23       Impact factor: 6.529

Review 2.  Effects of Lipid Overload on Heart in Metabolic Diseases.

Authors:  An Yan; Guinan Xie; Xinya Ding; Yi Wang; Liping Guo
Journal:  Horm Metab Res       Date:  2021-12-10       Impact factor: 2.936

3.  Wheel running improves fasting-induced AMPK signaling in skeletal muscle from tumor-bearing mice.

Authors:  Dennis K Fix; Brittany R Counts; Ashley J Smuder; Mark A Sarzynski; Ho-Jin Koh; James A Carson
Journal:  Physiol Rep       Date:  2021-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.